Astec LifeSciences Limited
ASTEC.NS

$251.53 M
Marketcap
$12.83
Share price
Country
$-0.10
Change (1 day)
$17.54
Year High
$9.81
Year Low
Categories

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

marketcap

Revenue of Astec LifeSciences Limited (ASTEC.NS)

Revenue in 2023 (TTM): $54.5 M

According to Astec LifeSciences Limited's latest financial reports the company's current revenue (TTM) is $54.5 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Astec LifeSciences Limited

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $54.5 M $4.87 M $-703,246 $-7,344,307 $-5,581,804
2022 $74.71 M $26.99 M $10.62 M $4.16 M $3.04 M
2021 $80.47 M $33.98 M $19.36 M $14.41 M $10.69 M
2020 $66 M $24.94 M $14.19 M $10.59 M $7.74 M
2019 $62.16 M $21.64 M $11.56 M $7.3 M $5.65 M
2018 $51.25 M $17.74 M $10.71 M $6.65 M $4.25 M
2017 $42.97 M $14.76 M $9.15 M $6.63 M $4.15 M
2016 $35.52 M $14.12 M $7.87 M $3.42 M $2.27 M
2015 $30.84 M $9.8 M $2.88 M $-2,074,501 $-2,279,364
2014 $31.7 M $9.99 M $6.37 M $2.26 M $1.76 M
2013 $24.62 M $7.3 M $4.28 M $1.33 M $1.03 M
2012 $20.79 M $6.78 M $3.13 M $1.04 M $707.87 K
2011 $13.42 M $4.18 M $1.88 M $215.48 K $162.41 K
2010 $13.02 M $2.89 M $1.88 M $828.17 K $582.62 K
2009 $13.31 M $3.85 M $3.03 M $2.04 M $1.57 M
2008 $10.04 M $3.28 M $2.57 M $1.48 M $1.23 M
2007 $6.56 M $2.52 M $1.88 M $1.12 M $944.99 K